Bariatric surgery is an effective treatment for morbid obesity with a sustained weight loss and improvements in metabolic syndrome. We present a label free quantitative shotgun proteomics approach to analyze the serum proteome of obese people who underwent Laparoscopic Gastric Plication (LGP) as a new bariatric surgery. Pre-surgery serum samples of obese individuals were compared with the serum of the same subjects 1e2 months post-surgery (T1) and 4e5 months post-surgery (T2). The data provide a list of 224 quantifiable proteins with at least two unique peptides that were quantifiable in at least 70% of samples. Gene ontology biological processes and molecular functions of differentially regulated proteins between pre-and post-surgery samples were investigated using WebGestalt online tool. In addition, molecular networks of differentially abundant proteins were determined through Ingenuity Pathway Analysis (IPA) software. This report is related to the research article entitled "Serum proteome changes and accelerated reduction of fat mass after Laparoscopic Gastric Plication in morbidly obese patients" (Savedoroudi et al. [1] ).
Consortium (http://proteomecentral.proteomexchange.org) via the PRIDE partner repository through the identifier PXD010528. © 2019 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons. org/licenses/by/4.0/).
Data
This report is associated with the research article aimed at investigating the effect of weight loss due to laparoscopic gastric plication (LGP) as a new bariatric surgical procedure on the human serum proteome [1] . A total of 288 proteins was identified using a shotgun label-free proteomics experiment, of which 224 proteins were quantifiable with at least two unique peptides in 70% of samples or more (Supplementary Table 1 ). The raw mass data have been deposited to the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org) via the PRIDE partner repository [2] with the dataset identifier PXD010528. The list of submitted proteomics raw-files into the ProteomeXchange and corresponding sample names are shown in Table 1 . Significantly regulated proteins between pre-and post-surgery samples were discussed in detail in Savedoroudi et al. [1] . Gene ontology enrichment analysis for biological process and molecular function of differentially regulated proteins at T1 and T2 are represented in Table 2 and Table 3 , respectively. In Table 4 , molecular networks of differentially regulated proteins are shown. Value of the data These data reveal the effect of laparoscopic gastric plication (LGP) on the proteome profile of obese people for the first time.
Data in this article provide information about the biological processes, molecular functions and molecular networks of differentially regulated proteins between pre-and post-surgery subjects. These findings provide new insight into the underlying molecular mechanism associated with laparoscopic gastric plication that could be useful for further study in development of non-surgical weight loss strategies. 
Study cohort and sample treatment
A total of 16 obese subjects undergoing LGP was investigated at three timepoints; pre-surgery (n ¼ 16), at 1e2 months post-surgery (T1, n ¼ 16), at 4e5 months post-surgery (T2, n ¼ 9). The detailed characteristics of patients were mentioned in Savedoroudi et al. [1] . The six most abundant serum proteins (albumin, IgG, IgA, antitrypsin, transferrin and haptoglobin) were depleted in the serum samples using the Agilent Multiple Affinity Removal column (4.6 Â 50 mm) according to the instructions recommended by the manufacturers (Agilent Technologies, CA, USA). Then, the filteraided sample preparation (FASP) protocol was utilized to prepare samples as described previously [1, 3] . Written consent was obtained from all participants and the institutional review board and the was used for further processing in Perseus post-analysis program and quantitative analysis.
proteinGroups.txt
File containing all proteins with corresponding label free quantitative information Table 2 Enrichment analysis of Gene ontology biological process and molecular function for differentially abundant proteins at T1, using WebGestalt online tool.
Gen set Description P-value
Overlap Gen-ID Biological Process GO:0051223 regulation of protein transport 4.87E-05 CRP, GPLD1, APOA1, APOA2, APOD, IL1RAP, LCP1, SRGN, RBP4, SAA1, CD14, ADIPOQ GO:0070201 regulation of establishment of protein localization 8.84E-05 CRP, GPLD1, APOA1, APOA2, APOD, IL1RAP, LCP1, SRGN, RBP4, SAA1, CD14, ADIPOQ GO:0034284 response to monosaccharide 0.000109 GPLD1, APOA2, SERPINF1, APOM, SPARC, THBS1, ADIPOQ GO:0032880 regulation of protein localization 0.000256 CRP, GPLD1, APOA1, APOA2, APOD, IL1RAP, LCP1, SRGN, RBP4, SAA1, CD14, ADIPOQ GO:0009743 response to carbohydrate 0.000315 GPLD1, APOA2, SERPINF1, APOM, SPARC, THBS1, ADIPOQ GO:0009746 response to hexose 0.000532 GPLD1, APOA2, SERPINF1, APOM, THBS1, ADIPOQ GO:0009749 response to glucose 0.000532 GPLD1, APOA2, SERPINF1, APOM, THBS1, ADIPOQ GO:0050707 regulation of cytokine secretion 0.000746 CRP, APOA1, APOA2, IL1RAP, SRGN, SAA1, CD14 GO:0051224 negative regulation of protein transport 0.00081 APOA1, APOA2, APOD, SRGN, ADIPOQ GO:1904950 negative regulation of establishment of protein localization 0.00081 APOA1, APOA2, APOD, SRGN, ADIPOQ Molecular Function GO:0005319 lipid transporter activity 0.00279 APOF, APOA1, APOA2, APOD, APOM, RBP4 GO:0005496 steroid binding 0.00279 GC, APOF, APOA1, APOA2, APOD, SHBG GO:0071813 lipoprotein particle binding 0.0101 CRP, APOA1, APOA2, THBS1 GO:0071814 protein-lipid complex binding 0.0101 CRP, APOA1, APOA2, THBS1 GO:0043178 alcohol binding 0.0105 APOF, APOA1, APOA2, APOD, RBP4 GO:0008289 lipid binding 0.0122 F10, GC, APOF, APOA1, APOA2, APOD, APOM, RBP4, SHBG, THBS1, CD14 GO:0005215 transporter activity 0.0128 GC, HBB, APOF, APOA1, APOA2, APOD, APOM, RBP4 GO:0022892 substrate-specific transporter activity 0.0170 HBB, APOF, APOA1, APOA2, APOD, APOM, RBP4
GO:0015485 cholesterol binding 0.0206 APOF, APOA1, APOA2, APOD GO:0032934 sterol binding 0.0206 APOF, APOA1, APOA2, APOD ethic committee of Shahid Beheshti University approved the study protocol for Human rights (IR.S-BU.ICBS.97/1019).
LC-MS/MS analysis
Initially, the peptides were resuspended in 2% acetonitrile, 0.1% FA and 0.1% trifluoroacetic acid. LC-MS/MS analysis was carried out on a UPLC-nanoESI MS/MS setup with a Dionex RSLC nanopump (Dionex, CA, USA). The system was coupled online with an emitter for nanospray ionization (New objective picotip 360-20-10) to a Q Exactive HF mass spectrometer (Thermo Scientific, Waltham, USA). The samples were analyzed in a random order, in triplicates. The peptide material was loaded onto a 2cm C18 trapping column (Dionex Acclaim PepMap RSLC C18) and separated using a 75cm C18 reversed-phase column (Dionex Acclaim PepMap RSLC C18). Both columns were kept at 60 C. The peptides were eluted with a gradient of 98% solvent A (0.1% FA) and 2% solvent B (0.1% FA in acetonitrile), which was increased to 8% solvent B on a 5-min ramp gradient and subsequently to 30% solvent B on a 45-min ramp gradient, at a constant flow rate of 300nL/min. The mass spectrometer was operated in positive mode using a Top15 data-dependent MS/MS scan method. A full MS scan in the 375e1500 m/z range was acquired at a resolution of 120 000 with an AGC target of 3 Â 10 6 and a maximum injection time of 50 ms. Fragmentation of precursor ions was performed by higher-energy C-trap dissociation with a normalized collision energy of 27. MS/MS scans were acquired at a resolution of 15000 with an AGC target of 2 Â 10 5 ; maximum injection time was 100 ms. Dynamic exclusion was set to 5s.
Data analysis and processing
Mass spectrometry data were analyzed in MaxQuant version 1.6.0.1 and searched against the Uniprot human reference FASTA database (August 2017) [4, 5] . Label-free protein quantitation (LFQ) algorithm was performed with a minimum ratio count of 1. Standard settings in MaxQuant were employed, including carbamidomethylation of cysteines as a fixed modification, and acetylation of protein N-terminals, oxidation of methionine, and deamidation of asparagine and glutamine as Table 3 Enrichment analysis of Gene ontology biological process and molecular function for differentially abundant proteins at T2, using WebGestalt online tool.
Gen set
Description P-value Overlap Gen-ID Biological Process GO:0010976 positive regulation of neuron projection development 0.000151 FN1, IL1RAP, NRP1 GO:0045666 positive regulation of neuron differentiation 0.000151 FN1, IL1RAP, NRP1 GO:0050769 positive regulation of neurogenesis 0.000151 FN1, IL1RAP, NRP1 GO:0051962 positive regulation of nervous system development 0.000151 FN1, IL1RAP, NRP1 GO:0010975 regulation of neuron projection development 0.000262 FN1, IL1RAP, NRP1 GO:0031346 positive regulation of cell projection organization 0.000416 FN1, IL1RAP, NRP1 GO:0045664 regulation of neuron differentiation 0.000416 FN1, IL1RAP, NRP1 GO:0050767 regulation of neurogenesis 0.000618 FN1, IL1RAP, NRP1 GO:0051960 regulation variable modifications. A maximum of two tryptic missed cleavages was allowed. The false discovery rate (FDR) of identified proteins and peptides was set to a maximum of 1%, using a target-decoy fragment spectra search strategy. Hereby, high confidence identifications were ensured. The "match between runs" feature was enabled to transfer peptide identifications across LC-MS/MS runs, based on accurate retention time and mass-to-charge. The output from MaxQuant, containing the list of proteins identified below 1% FDR, was further filtered and processed in Perseus version 1.6.0.2 [6] . All reverse hits and proteins identified only by site were removed from further analysis, and the data were log 2transformed. At least two unique peptides were required for a protein quantitation. Additionally, the unique peptides were required to be quantifiable in at least 70% of samples.
Bioinformatics analysis
Differentially regulated proteins between pre-and post-surgery subjects were functionally categorized based on gene ontology (GO) classification using WEB-based GEne SeT AnaLysis Toolkit (WebGestalt) [7] . Identification of networks was performed with Ingenuity Pathway Analysis software (IPA; Ingenuity Systems, Redwood City, CA, www.ingenuity.com). Gene symbols and the corresponding protein fold change were imported to IPA software using core analysis. Standard settings in IPA were employed, including: direct and indirect relationships between focused molecules with default settings of 35 molecules/network, based on experimentally observed data (high confidence Akt, ANGPTL1, B4GALT5, C4BPB, CHST3, CLEC10A, Collagen type VI, CRP, Enolase, ERK, ERK1/2, EXT1, Fc gamma receptor, Fc receptor, FCER1A, FCN1, FN1, GFRA2, HS6ST1, IL1, IL6, IL1RAP, ITIH3, miR-191-5p (and other miRNAs w/seed AACGGAA), NFkB (complex), NfkB1-RelA, NRP1, PRG4, PRSS38, pyridoxamine, S100A12, SEMA3D, SHBG, Stat3-Stat3, TGFB1
predictions and moderate confidence interactions excluded) were considered. All sources of data from human, mouse and rat studies in the Ingenuity Knowledge Base were included.
